(Reuters) - The U.S. Food and Drug Administration on Thursday approved a new drug for advanced colon cancer developed by Bayer AG, a month ahead of the agency's expected action date for a decision. The drug, to be sold under the brand name Stivarga, was approved to treat colon cancer that has progressed after prior treatment or that has spread to other parts of the body, the agency said. "Someone has clearly lit a fire under the FDA," Sanford Bernstein analyst Geoffrey Porges said of the speedy approval. ...
Source: http://news.yahoo.com/novo-nordisk-says-diabetes-drug-approved-japan-052511113--finance.html
London 2012 closing ceremony Shark Week 2012 evelyn lozada UFC 150 Caster Semenya Medal Count 2012 Olympics victoria beckham
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.